[Bacteriological development in the triple combination antituberculosis treatment]

Rev Med Chil. 1966 Jul;94(7):442-5.
[Article in Spanish]
No abstract available

MeSH terms

  • Aminosalicylic Acids / therapeutic use*
  • Drug Resistance, Microbial
  • Humans
  • Isoniazid / therapeutic use*
  • Streptomycin / therapeutic use*
  • Thioacetazone / therapeutic use
  • Tuberculosis / drug therapy*
  • Tuberculosis / prevention & control

Substances

  • Aminosalicylic Acids
  • Thioacetazone
  • Isoniazid
  • Streptomycin